Elevated expression of SIGLEC8 in skin cutaneous melanoma predicts better prognosis associated with hematopoietic cell lineage pathway
{{output}}
Background: Cutaneous melanoma (SKCM) is becoming more common. Current prognostic markers-TNM stage, BRAF mutation status, and tumor mutational burden (TMB)-do not offer precise predictions. Recent studies point to a key role for... ...
